期刊文献+

血浆脑钠素水平对心血管病患者远期病死率的预测作用 被引量:1

Prediction of Long- term Mortality by Brain Natriuretic Peptide in Patients with Cardiovascular Diseases
在线阅读 下载PDF
导出
摘要 目的 本研究主要探讨血浆BNP水平对心血管患者远期病死率及预后的影响.方法 对笔者医院2003年5月~2005年2月期间住院的患者,共276例,失访2例,随访7年,根据BNP水平分为BNP〈100ng/L、101~1000ng/L、1001~5000ng/L、〉5000ng/L 4组,比较各组间病死率,绘制生存曲线.结果 随访期间,91例患者死亡,其中心源性死亡50例,非心源性死亡41例.4组比较,各组间病死率比较差异有统计学意义(P=0.000),随BNP浓度的增加,病死率逐渐升高.在多因素比较中,BNP、年龄和EF值差异均有统计学意义(P〈0.05),BNP是影响患者预后的独立危险因素,BNP〉5000ng/L组,3个月的病死率为超过50%,5年的病死率为100%.结论 BNP水平是影响病死率的一个独立危险因素,BNP〉5000ng/L,近期及远期预后均严重不良. Objective To explore the effeclt of brain natriuretic peptide(BNP) of long-term mortality and prognostic value in patients with cardiovascular diseases. Methods A total of 276 patients with cardiovascular diseases were enrolled, and followed up for 7 years. They were divided into three groups according to the level of plasma BNP: BNP〈100ng/L; group 2, 101-1000ng/L; 1001-5000ng/L;group 4, BNP〉5000ng/L. All causes of mortality were examined in relation to BNP levels during follow up. COXregression was used to assess the relevance of baseline characteristics to risk of death. Results All cause death occurred in 91(33%) subjects. Higher levels of plasma BNP were related to higher mortality. COX regression showed BNP was significantly associated with a increased risk for all-cause mortality(P=0.000). In group 4, the mortality was 53.8% in three months and 100% in five years follow up. Conclusion BNP is a biochemical marker of increased risk of long-term all-cause mortality in patients with cardiovascular diseases.
出处 《医学研究杂志》 2016年第3期138-141,共4页 Journal of Medical Research
关键词 脑钠素 心力衰竭 病死率 心血管疾病 Brain natriuretic peptide Heart failure Mortality Cardiovascular diseases
  • 相关文献

参考文献12

  • 1Cowie MR, Jourdain P, Maisel A, et al. Clinical applications of B - type natriuretic peptide (BNP) testing[ J]. Eur Heart J, 2003, 24 (19) :1710 - 1718.
  • 2Daniels LB, Maisel AS. Natriuretic peptides[ J]. J Am Coil Cardiol, 2007, 50 (25) :2357 - 2368.
  • 3Dickstein K, Cohen - Solal A, Filippatos G, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 : the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)[J]. Eur J Heart Fail, 2008,10(10):933-989.
  • 4Oremus M, Don -Wauchope A, MeKelvie R, et al. BNP and NT- proBNP as prognostic markers in persons with chronic stable heart fail- ure[J]. J Heart Failure Reviews, 2014,19(4) :471 -505.
  • 5Gaggin HK, Mohammed AA, Bhardwaj A, et al. Heart failure out- comes and benefits of NT - proBNP - guided management in the elder-ly: results from the prospective, randomized ProBNP outpatient tailor- ed chronic heart failure therapy (PROTECT) study [ J]. J Cardiac Failure,2012,18(8) : 626 -634.
  • 6Troughton RW, Frampton CM, Brunner- La Rocca HP, et al. Effect of B - type natriuretic peptide - guided treatment of chronic heart fail- ure on total mortality and hospitalization: an individual patient meta - analvsis[J]. Eu Heart J. 2014,35 ( 23 ) : 1559 - 1567.
  • 7Mohammed AA, Januzzi JL Jr. Natriuretic peptide guided heart failure management [ J ]. Curr Clin Pharmacol, 2009,4 (2) : 87 - 94.
  • 8Masson S, Latini R, Anand IS, et al. Direct comparison of B -type natriuretic peptide (BNP) and amino - terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure ( Val - HEFT) data [ J ]. Clin Chem, 2006, 52(8) :1528 - 1538.
  • 9Faggiano P, Valle R, Aspromonte N, et al. How often we need to measure brain natriuretic peptide (BNP) blood levels in patients ad- mitted to the hospital for acute severe heart failure? Role of serial measurements to improve short- term prognostic stratification[J]. Int J Cardiol, 2010,140(1) :88 -94.
  • 10Porapakkham P, Porapakkham P, Zimmet H, et al. B - type natri- uretic peptide - guided heart failure therapy : a meta - analysis [ J ]. Arch Intern Med, 2010, 170(6) :507 -514.

同被引文献15

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部